Treatment of anal high-grade squamous intraepithelial lesions
↓downin humans1−57%
1 study
Treatment of anal high-grade squamous intraepithelial lesions lower the risk of anal cancer in humans (anal high-grade squamous intraepithelial lesions in ANCHOR trial) (57%).
Reviewanal high-grade squamous intraepithelial lesions in ANCHOR trial
Treating anal high-grade squamous intraepithelial lesions lower the risk of anal cancer in humans (anal high-grade squamous intraepithelial lesions (HSILs)).
National Cancer Institute$14.8MGouvernement du Canada | Canadian Institutes of Health ResearchCA$1MNational Institute of Biomedical Imaging and Bioengineering$704K
Adjusted hazard ratios for gastrointestinal cancer mortality were 2.54 for mild, 2.51 for moderate, and 2.96 for severe underweight compared with the reference group…Adjusted hazard ratios for gastrointestinal cancer mortality were 2.54 for mild, 2.51 for moderate, and 2.96 for severe underweight compared with the reference group (25.0–29.9 kg/m²).